Search

Your search keyword '"Engelborghs, Sebastiaan"' showing total 2,454 results

Search Constraints

Start Over You searched for: Author "Engelborghs, Sebastiaan" Remove constraint Author: "Engelborghs, Sebastiaan"
2,454 results on '"Engelborghs, Sebastiaan"'

Search Results

1. Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies

2. Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study

3. Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method

6. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease

8. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

10. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

13. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

15. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

16. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

17. New insights into the genetic etiology of Alzheimer’s disease and related dementias

18. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

20. Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

21. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

23. Accelerated Cognitive Decline Associated With Hearing Loss and Bilateral Vestibulopathy: Insights From a Prospective Cross-Sectional Study Using the Repeatable Battery for the Assessment of Neuropsychological Status Adjusted for the Hearing Impaired in the DFNA9 Population

24. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study.

25. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.

27. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

30. Attitudes toward pre-symptomatic screening for Alzheimer’s dementia in five European countries: a comparison of family members of people with Alzheimer’s dementia versus non-family members

32. Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia

33. CSF proteome profiling identifies novel biomarkers for Frontotemporal Dementia and its pathological subtypes

34. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

37. Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects

38. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis

39. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

40. Pre-analytical stability of novel cerebrospinal fluid biomarkers

44. Inflammatory biomarkers in Alzheimer's disease plasma

45. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

46. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

47. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

48. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.

50. Is vestibular function related to human hippocampal volume?

Catalog

Books, media, physical & digital resources